Article info
Spoken sessions
α1-Antitrypsin: what it tells us about COPD
S63 Use of NMR spectroscopy and nanospray mass spectrometry to characterise binding of lead compounds for drug design in α1-antitrypsin deficiency
Citation
S63 Use of NMR spectroscopy and nanospray mass spectrometry to characterise binding of lead compounds for drug design in α1-antitrypsin deficiency
Publication history
- First published November 16, 2010.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.